Report overview
The coronavirus (COVID-19) is an infectious disease caused by the novel coronavirus. Those affected by COVID-19 are likely to experience mild to moderate respiratory illness and recover without requiring special treatment, but people in the age group of 50 years and above, and those and suffering from other health disorders such as hypertension, diabetes, and kidney failure are at a severe risk of infection and require specific treatment. Moreover, currently there is no medication for treating the coronavirus, and health physicians are suggesting corticosteroids, anti-viral therapies for individuals with severe symptoms.
This report aims to provide a comprehensive presentation of the global market for Coronavirus Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Treatment Drugs. This report contains market size and forecasts of Coronavirus Treatment Drugs in global, including the following market information:
Global Coronavirus Treatment Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Coronavirus Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Corticosteroids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Coronavirus Treatment Drugs include Serum Institute of India, Pfizer Inc, AstraZeneca Plc, Bharat Biotech International Limited, Cadila Healthcare Limited, Johnson & Johnson, Moderna, GlaxoSmithKline Plc and CanSino Biologics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Coronavirus Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coronavirus Treatment Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Coronavirus Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Corticosteroids
Anti-viral
Monoclonal Antibodies
Kinase Inhibitors
Others
Global Coronavirus Treatment Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Coronavirus Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Coronavirus Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Coronavirus Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coronavirus Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Coronavirus Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Serum Institute of India
Pfizer Inc
AstraZeneca Plc
Bharat Biotech International Limited
Cadila Healthcare Limited
Johnson & Johnson
Moderna
GlaxoSmithKline Plc
CanSino Biologics
Sinovac Biotech
Novavax, Inc
Glenmark Pharmaceuticals Limited
Dr. Reddy's Laboratories
Merck & Co., Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Coronavirus Treatment Drugs, market overview.
Chapter 2: Global Coronavirus Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Coronavirus Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Coronavirus Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
